Boston Therapeutics Cash Flow - Quarterly (OTCBB:BTHE)

Add to My Stocks
$0.05 $0 (0%) BTHE stock closing price Sep 21, 2018 (Closing)

The Boston Therapeutics cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the Boston Therapeutics debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Boston Therapeutics revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Boston Therapeutics saw a cash impact of $- from the buyback of BTHE shares. The cash flow statement helps in the Boston Therapeutics stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Boston Therapeutics had an outflow of $-0.48M from operating activities, $- spend due to financing activities, and $- outflow due to investing activities till 2018 Q2.

View and download details of Boston Therapeutics cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--1.57M1.3M--1.09M---
Net Increase (Decrease) in Assets Liabilities----0.09M-0.14M----0.08M-0.11M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.6M2.04M-1.36M-0.66M-0.86M-0.01M1.2M3.67M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment----------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities------2.15M2.15M--
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-------0.25M-0.25M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year----3.38M-----
Cash & Equivalents at Year End----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Lexicon Pharma financial analysis

Boston Therapeutics stock price history provides insight into historical stock price fluctuations, and Boston Therapeutics stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Boston Therapeutics had a Net Change in Cash and Cash Equivalents of $-0.1M in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Boston Therapeutics stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Boston Therapeutics reported a negative operating cash flow of $-0.48M till 2018 Q2 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Boston Therapeutics used $- cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Boston Therapeutics spent $- from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Boston Therapeutics Cash Flow

Quarterly Cash Flow Statements For Boston Therapeutics Inc Peers

Biostar Pharma cash flow, Integrated Biopharma cash flow, Lexicon Pharma cash flow